(Q36717925)

15 August 2017

1 reference

title

Introduction to imaging brain tumor metabolism with positron emission tomography (PET). (English)

1 reference

positron emission tomography

15 August 2017

main subject

1 reference

1 reference

Conti PS

1

1 reference

15 August 2017

publication date

1 January 1995

1 reference

15 August 2017

1 reference

15 August 2017

volume

13

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

244-259

1 reference

Advances in medical imaging for cancer diagnosis and treatment

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Prediction of survival in glioma patients by means of positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Positron emission tomographic evaluation of radiochemotherapeutic effect on regional cerebral hemocirculation and metabolism in patients with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Early and late stage positron emission tomography (PET) studies on the haemocirculation and metabolism of seemingly normal brain tissue in patients with gliomas following radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Stereotaxic biopsy and positron emission tomography correlation of cerebral gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Positron emission tomography in patients with glioma. A predictor of prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Complementary roles of PET and MR spectroscopy in the management of brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Glucose uptake by gliomas after treatment. A positron emission tomographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Cerebral diaschisis in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Positron emission tomography in the detection of malignant degeneration of low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

The normal pituitary examined with positron emission tomography and (methyl-11C)-L-methionine and (methyl-11C)-D-methionine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Breast cancer: PET imaging of estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

THE ORGANIZATION AND DUPLICATION OF CHROMOSOMES AS REVEALED BY AUTORADIOGRAPHIC STUDIES USING TRITIUM-LABELED THYMIDINEE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

The relationship of thymidine metabolism to the use of fractional incorporation as a measure of DNA synthesis and tissue proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Labeled putrescine as a probe in brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Positron emission tomography in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Brain tumor imaging with synthesized 18F-fluorophenylalanine and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Evaluation of [1-11C]-alpha-aminoisobutyric acid for tumor detection and amino acid transport measurement: spontaneous canine tumor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Sigma and opioid receptors in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Use of 2-deoxy-D[1-11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Increased expression of glycolysis-associated genes in oncogene-transformed and growth-accelerated states

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

A radiologist looks at AIDS: imaging evaluation based on symptom complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Neuroradiologic findings in AIDS: a review of 200 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Inflammatory neuropathy in homosexual men with lymphadenopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Intracranial lesions in the acquired immunodeficiency syndrome. Radiological (computed tomographic) features.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Central nervous system mass lesions in the acquired immunodeficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Demonstration of lesions of cerebral toxoplasmosis by computerized tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

The AIDS dementia complex: I. Clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Primary central nervous system lymphoma: CT and pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Radiographic findings in 32 cases of primary CNS lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Cranial CT in acquired immunodeficiency syndrome: spectrum of diseases and optimal contrast enhancement technique

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Synthesis and purification of the anti-viral agent 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine (FIAC) labeled with iodine-125.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

Positron emission tomography: a financial and operational analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909509011694

10.3109/07357909509011694

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference